Перевести на Переведено сервисом «Яндекс.Перевод»
IVAO Index
308,58 (14,30%)
How does this work? Site map Contacts Database
Ru
IVAO Index
308,58 (14,30%)
МЕНЮ
Translate Page Original Page
Home
News
Breaking News by tag «FDA»

Breaking News by tag «FDA»

Popular Tags
research medical and health science cancer health Hi-Tech DNA aging medicine COVID-19 Industry stem cells brain genomics Alzheimer's disease diabetes vaccine heart Parkinson’s disease Illness dementia study HIV life hiv longevity FDA blood business industry RNA medical technology Alzheimer investment CRISPR 3D printing Immunology obesity biology genome infection cells parkinson artificial intelligence transplant biotechnology WHO financing coronavirus genetics
FDA approves imaging drug to help identify lung cancer lesions

The U.S. Food and Drug Administration has approved a new indication for Cytalux (pafolacianine) to assist surgeons in identifying lung cancer lesions in adult patients with known or suspected lung cancer.

FDA
FDA Approves First Fecal Microbiota Product

Rebyota Approved for the Prevention of Recurrence of Clostridioides difficile Infection in Adults
FDA
FDA Warns of Risks Associated with Non-Invasive Prenatal Screening Tests

Inappropriate interpretation of results may lead to potentially improper medical decisions
FDA
Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s (BIIB.O) Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
FDA Alzheimer's disease
FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma

The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy. Abecma is the first cell-based gene therapy approved by the FDA for the treatment of multiple myeloma.
FDA
FDA Authorizes First COVID-19 Test for Self-Testing at Home

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results. The Lucira COVID-19 All-In-One Test Kit is a molecular (real-time loop mediated amplification reaction) single use test that is intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19.
FDA COVID-19
FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality

The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy approved to treat children less than two years of age with spinal muscular atrophy (SMA), the most severe form of SMA and a leading genetic cause of infant mortality.
FDA
FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression).
FDA
1 2 3
Site Map